Lapatinib potentiates cytotoxicity of YM155 in neuroblastoma via inhibition of the ABCB1 efflux transporter-Reference-Cited by-同舟云学术

Lapatinib potentiates cytotoxicity of YM155 in neuroblastoma via inhibition of the ABCB1 efflux transporter

Published:2017-06-08 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Radic-Sarikas Branka^ORCID,Halasz Melinda^ORCID,Huber Kilian V. M.^ORCID,Winter Georg E.,Tsafou Kalliopi P.,Papamarkou Theodore^ORCID,Brunak Søren,Kolch Walter^ORCID,Superti-Furga Giulio^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-03129-6.pdf

Reference40 articles.

1. Gurney, J. G. et al. Infant Cancer in the U.S.: Histology-Specific Incidence and Trends, 1973 to 1992. J. Pediatr. Hematol. Oncol. 19 (1997).

2. Maris, J. M., Hogarty, M. D., Bagatell, R. & Cohn, S. L. Neuroblastoma. Lancet 369, 2106–2120, doi: 10.1016/S0140-6736(07)60983-0 (2007).

3. Smith, M. A. et al. Outcomes for Children and Adolescents With Cancer: Challenges for the Twenty-First Century. J. Clin. Oncol. 28, 2625–2634, doi: 10.1200/JCO.2009.27.0421 (2010).

4. Gatta, G. et al. Childhood cancer survival in Europe 1999–2007: results of EUROCARE-5—a population-based study. Lancet Oncol. 15, 35–47, doi: 10.1016/S1470-2045(13)70548-5 (2014).

5. Brodeur, G. M. Molecular basis for heterogeneity in human neuroblastomas. Eur. J. Cancer 31, 505–510, doi: 10.1016/0959-8049(95)00040-P (1995).

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PRMT5 orchestrates EGFR and AKT networks to activate NFκB and promote EMT;2024-01-04

2. Investigation of the anticancer mechanism of monensin via apoptosis‐related factors in SH‐SY5Y neuroblastoma cells;Clinical and Translational Science;2023-08-03

3. Therapy resistance in neuroblastoma: Mechanisms and reversal strategies;Frontiers in Pharmacology;2023-02-16

4. Available Preclinical Tools for Neuroblastoma;Handbook of Animal Models and its Uses in Cancer Research;2023

5. ERBB and P‐glycoprotein inhibitors break resistance in relapsed neuroblastoma models through P‐glycoprotein;Molecular Oncology;2022-11-05